ABL Diagnostics cuts cash allocation to liquidity contract by EUR 50,000

ABL Diagnostics cut cash allocated to its liquidity contract with Invest Securities by EUR 50,000 on Sept. 18, 2026. Post-adjustment resources stood at 27,852 shares, EUR 43,873.58 in cash at the market close. At the June 30, 2026 semiannual review, the liquidity account held 33,993 shares, EUR 76,654.75 in cash. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABL Diagnostics SA published the original content used to generate this news brief via (Ref. ID: 20260918821374) on September 18, 2026, and is solely responsible for the information contained therein. (C)